Lilly Posts 23% Rise in Profit on Solid Sales - Wall Street Journal
Lilly Posts 23% Rise in Profit on Solid Sales Wall Street Journal Associated Press Lilly is among a slew of pharmaceutical firms that have raised some drug prices aggressively even as government and private insurers struggle to rein in health-care costs. The list price of Zyprexa has increased 11.5% and ... |


